Now that the selection has been made, the rest of the bidding process goes quickly.
Three days later, the bidding meeting was successfully held.
Major pharmaceutical companies have already obtained the news from their own channels in advance.
They all submitted their bids in a tacit understanding and then quietly waited for the final results.
But they did not return empty-handed. Instead, they signed another contract with Sanqing and packaged up the discarded prescriptions they brought and sold them at a discounted price.
Each company does not have many abandoned prescriptions. Domestic pharmaceutical companies generally have about five or six, and multinational giants only have a dozen. Most of them are prescriptions that they have carefully selected and can no longer squeeze out any potential.
The research and development level of domestic enterprises is generally relatively low, lagging behind overseas countries by nearly two decades. There are very few new drugs in abandoned prescriptions, and most of them are improved prescriptions.
They are very self-aware, so they accepted a friendly price of one million, mainly because they wanted to establish good relations with Sanqing so that they could cooperate in the domestic market in the future.
After all, everyone knows very well that in this bidding, the protagonists must be foreign pharmaceutical companies. Sanqing’s primary goal is to sell overseas licenses to earn money as soon as possible to recover costs.
When Sanqing starts to develop the domestic market, we might as well talk about mutual authorization and cooperation.
After all, Sanqing only stands out with its anti-cancer drugs, and in other fields it is still unable to compare with some powerful domestic large pharmaceutical companies.
It is very common for pharmaceutical companies to authorize each other and cooperate with each other, especially domestic pharmaceutical companies. Each has its own specialization. If they work together and complement each other, they can continuously expand the market and enhance their own strength.
Multinational giants have also packaged and sold discarded prescriptions to Sanqing. Their R&D capabilities are among the best in the world, and they are more confident in their discarded prescriptions. They all firmly believe that with Sanqing’s R&D level, it is absolutely impossible to find other applications for them. direction.
In short, Wei Kang's abandoned prescription warehouse is full and extremely fulfilling.
A few days later, the conference hall of Sanqing Pharmaceutical was decorated again.
A red banner hung high, reading "Signing Ceremony of Overseas Authorization Cooperation between Sanqing Pharmaceutical and Pfizer."
Wei Kang signed a contract with the CEO of Pfizer, who made a special trip. The two parties exchanged signatures and took photos.
The flashlights of media reporters kept flashing to take pictures of this historic event.
There was also Gao Tuoyu, a major leader at the municipal level, present. This time Bureau Xie from the Municipal Food and Drug Administration could only stay aside and stand with Andre.
Originally, such a large cooperation project alarmed the provincial leaders, but time was short, so only the municipal leaders came, but they brought the warm concern of the provincial leaders to show their level of attention.
Gao Tuoyu shook hands with Wei Kang cordially and smiled particularly amiably: "Mr. Wei, Sanqing Pharmaceutical has not only brought glory to the city, but also attracted the attention of the province. Recently, the city is responding to the national call to actively support the development of high-tech enterprises. You really gave us a big surprise."
"And this project is also very important. It's 3 billion US dollars, more than 20 billion US dollars."
Wei Kang smiled and said: "I still want to thank all the leaders for their support. Besides, it's not that much after tax."
Gao Tuoyu laughed, looked to the left and right and said, "Mr. Wei is indeed a people's entrepreneur. He is the first to think about paying taxes after signing a big contract."
The leaders on the left and right also laughed with appreciation.
Gao Tuoyu patted Wei Kang on the shoulder and said with a smile: "Okay, let me tell you another piece of good news. Last week, Bureau Xie of the Food and Drug Administration helped you apply for the National Major New Drug Creation Special Annual Project. Now it is estimated that it has arrived at the General Administration. There, I don’t think it’s a big problem.”
"As long as it passes, you will be able to get a series of tax-free preferential policies this year, as well as provincial project funds. For those who complete the clinical phase I, II, and III studies of new drugs, they will be given up to 1 million yuan and 2 million yuan respectively. and 3 million yuan in funding.”
"Although President Wei is very wealthy now and may not need this funding much, this tax-free preferential policy is still very powerful and I think President Wei will still be satisfied."
He then said with great concern: "Mr. Wei, the province attaches great importance to and supports Sanqing Pharmaceutical. The company's headquarters should not be moved."
"You have abundant funds now, so you definitely need to renovate and expand production. Our land resources in Kunming are still abundant, and the prices are very favorable. I think there are several suitable pieces of land not far from you in the industrial park. If Mr. Wei needs industrial You can boldly mention the land."
When Sanqing Pharmaceutical's new drugs are put into production, they will continue to receive tax revenue and stimulate local employment. If they grow in the future, they will also drive the development of Kunming's pharmaceutical industry. These are all things Gao Tuoyu attaches great importance to.
After all, Kunshi is only a small third- and fourth-tier city, inferior to nearby first- and second-tier cities in all aspects. He is also afraid that Wei Kang will relocate his headquarters to Haishi or Suzhou, so naturally he has to work hard to win over Sanqing, who is laying eggs. Hen is firmly tied to the development train of Kunming City.
Wei Kang smiled and nodded, circling among the crowd.
US$3 billion is indeed a large amount, but according to the agreement, it will be paid in three installments, an upfront payment of 500 million, and a milestone payment of 2.5 billion after registration and sales start.
So in fact, he only received US$500 million at the beginning, and he will not receive subsequent payments until at least the Eagle Country FDA registration is successful.
If there are any serious adverse reactions in subsequent clinical trials and the company fails to pass the strict requirements of the FDA, not only will the subsequent money be lost, but all the money paid in advance will also have to be returned.
This is an insurance policy that Pfizer has added to themselves. After all, the new drug has not been in clinical trials for a long time, so they are not completely reassured.
Wei Kang agreed to Pfizer's request because he could guarantee that the drug would never have any serious adverse reactions.
Representatives of other pharmaceutical companies at the scene also looked at the CEOs of Weicome and Pfizer with great envy.
The US$3 billion overseas licensing cooperation agreement is just the beginning.
It should be the largest authorized cooperation in China so far.
They all want this kind of sky-high licensing cooperation.
Whether it is licensing out or buying licenses, people are envious and jealous.
Not to mention Pfizer, after all, it is a multinational giant.
But Wei Kang is just a young man in his twenties.
In the blink of an eye, he was worth tens of billions.
From a small boss of a pharmaceutical company on the verge of bankruptcy, he suddenly became a millionaire.
Just one anti-cancer prescription inspired by discarded prescriptions.
Simply a legend.
It’s as legendary as Pfizer’s Ivanco.
Moreover, Wei Kang is the only major shareholder of Sanqing Pharmaceutical.
Although this net worth is still far away from the position of the richest man in pharmaceutical companies.
But this is pure cash flow, which is much better than many listed companies that are insolvent and have profits of only tens of millions.
Not to mention the huge financial resources that will come after the anti-cancer drug is put into production.
I believe that within a few years, Wei Kang will be on the domestic wealth list.
The media were all as excited as chicken blood. They chased Wei Kang and kept asking questions.
Mr. Wei, were you good at studying when you were a child?
Mr. Wei, did you win any prizes in middle school?
Mr. Wei, tell me about your college days. Did you study hard all day long?
Mr. Wei, are you single now? How many girlfriends have you had?
Mr. Wei, what impact has your parents’ death had on you?
When Wei Kang heard the last question, his face turned dark, and he secretly wrote this reporter down in his notebook.
Such an ignorant media must block him and never see him again.
